PharmacyCodes



4-Amino-5-hexenoic acid en es it fr

4-Amino-5-hexenoic acid Brand names, 4-Amino-5-hexenoic acid Analogs

4-Amino-5-hexenoic acid Brand Names Mixture

  • No information avaliable

4-Amino-5-hexenoic acid Chemical_Formula

C6H11NO2

4-Amino-5-hexenoic acid RX_link

No information avaliable

4-Amino-5-hexenoic acid fda sheet

4-Amino-5-hexenoic acid msds (material safety sheet)

4-Amino-5-hexenoic acid Synthesis Reference

No information avaliable

4-Amino-5-hexenoic acid Molecular Weight

129.157 g/mol

4-Amino-5-hexenoic acid Melting Point

No information avaliable

4-Amino-5-hexenoic acid H2O Solubility

55.1 mg/mL

4-Amino-5-hexenoic acid State

Solid

4-Amino-5-hexenoic acid LogP

0.056

4-Amino-5-hexenoic acid Dosage Forms

Powder (500 mg sachets); Tablet (500 mg)

4-Amino-5-hexenoic acid Indication

For use as an adjunctive treatment (with other drugs) in treatment resistant epilepsy, complex partial seizures, secondary generalized seizures, and for monotherapy use in infantile spasms in West syndrome.

4-Amino-5-hexenoic acid Pharmacology

Vigabatrin, is an anticonvulsant chemically unrelated to other anticonvulsants. Vigabatrin inhibits the catabolism of GABA. It is an analog of GABA, but it is not a receptor agonist.

4-Amino-5-hexenoic acid Absorption

Rapidly absorbed following oral administration. Food may slightly decrease the rate, but not the extent, of absorption.

4-Amino-5-hexenoic acid side effects and Toxicity

No information avaliable

4-Amino-5-hexenoic acid Patient Information

This medicine may reduce your ability to drive or operate machinery safely. Do not drive or operate machinery until you know how this medicine affects you and you are sure it won't affect your performance. Avoid stopping this medicine suddenly. The dose of this medicine should be gradually decreased over a period of two to four weeks. After months to years of taking this medication, damage to vision may occur. Regular eye examinations should be conducted and notify your doctor if any change in vision occurs.

4-Amino-5-hexenoic acid Organisms Affected

Humans and other mammals